159 related articles for article (PubMed ID: 33857031)
21. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
[TBL] [Abstract][Full Text] [Related]
22. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
[TBL] [Abstract][Full Text] [Related]
23. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
24. Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Frezza AM; Beale T; Bomanji J; Jay A; Kalavrezos N; Dileo P; Whelan J; Strauss SJ
BMC Cancer; 2014 Jan; 14():23. PubMed ID: 24422949
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for patients with sarcomas of the pelvic bones.
Kawai A; Healey JH; Boland PJ; Lin PP; Huvos AG; Meyers PA
Cancer; 1998 Mar; 82(5):851-9. PubMed ID: 9486573
[TBL] [Abstract][Full Text] [Related]
26. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.
Ozaki T; Flege S; Kevric M; Lindner N; Maas R; Delling G; Schwarz R; von Hochstetter AR; Salzer-Kuntschik M; Berdel WE; Jürgens H; Exner GU; Reichardt P; Mayer-Steinacker R; Ewerbeck V; Kotz R; Winkelmann W; Bielack SS
J Clin Oncol; 2003 Jan; 21(2):334-41. PubMed ID: 12525527
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of lymphovascular tumor invasion in localized high-grade osteosarcoma: Outcomes of a single institution over 10 years.
Gusho CA; Miller I; Clayton B; Colman MW; Gitelis S; Blank AT
J Surg Oncol; 2021 Jun; 123(7):1624-1632. PubMed ID: 33621357
[TBL] [Abstract][Full Text] [Related]
28. Osteosarcoma after the age of fifty: A clinicopathological study.
Tempelaere C; Biau D; Babinet A; Anract P
Eur J Surg Oncol; 2019 Jul; 45(7):1288-1292. PubMed ID: 31014986
[TBL] [Abstract][Full Text] [Related]
29. Transarticular invasion of iliopelvic sarcomas into the sacrum. Radiological analysis of 47 cases.
Ozaki T; Lindner N; Hillmann A; Link T; Winkelmann W
Acta Orthop Scand; 1997 Aug; 68(4):381-3. PubMed ID: 9310044
[TBL] [Abstract][Full Text] [Related]
30. [Hemipelvectomy for the treatment of high-grade sarcomas: Pronostic of chondrosarcomas compared to other histological types].
Arnal-Burró J; Calvo-Haro JA; Igualada-Blazquez C; Gil-Martínez P; Cuervo-Dehesa M; Vaquero-Martín J
Rev Esp Cir Ortop Traumatol; 2016; 60(1):67-74. PubMed ID: 26091572
[TBL] [Abstract][Full Text] [Related]
31. Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study.
Evrard R; Schubert T; Paul L; Docquier PL
Orthop Traumatol Surg Res; 2019 Jun; 105(4):781-787. PubMed ID: 30982774
[TBL] [Abstract][Full Text] [Related]
32. Osteosarcoma of the pelvis. Oncologic results of 40 patients.
Kawai A; Huvos AG; Meyers PA; Healey JH
Clin Orthop Relat Res; 1998 Mar; (348):196-207. PubMed ID: 9553553
[TBL] [Abstract][Full Text] [Related]
33. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
[TBL] [Abstract][Full Text] [Related]
34. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and survival rate of osteosarcoma: A single-institution study.
Faisham WI; Mat Saad AZ; Alsaigh LN; Nor Azman MZ; Kamarul Imran M; Biswal BM; Bhavaraju VM; Salzihan MS; Hasnan J; Ezane AM; Ariffin N; Norsarwany M; Ziyadi MG; Wan Azman WS; Halim AS; Zulmi W
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e104-e110. PubMed ID: 25870979
[TBL] [Abstract][Full Text] [Related]
36. Secondary chondrosarcoma arising from osteochondroma: outcomes and prognostic factors.
Tsuda Y; Gregory JJ; Fujiwara T; Abudu S
Bone Joint J; 2019 Oct; 101-B(10):1313-1320. PubMed ID: 31564158
[TBL] [Abstract][Full Text] [Related]
37. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic features and prognosis of osteosarcoma in Turkish adults.
Seker MM; Seker A; Aksoy S; Ozdemir N; Uncu D; Zengin N
Asian Pac J Cancer Prev; 2014; 15(8):3537-40. PubMed ID: 24870753
[TBL] [Abstract][Full Text] [Related]
39. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.
Kim W; Han I; Lee JS; Cho HS; Park JW; Kim HS
J Surg Oncol; 2018 May; 117(6):1223-1231. PubMed ID: 29409122
[TBL] [Abstract][Full Text] [Related]
40. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
